The information below details the components of this test. For overall setup schedule, see Performing lab & setup schedule.
Test code | Test name | Orderable separately | Setup schedule |
|---|---|---|---|
| %206 | ACETYLCHOLINE RECEPTORBINDING ANTIBODY | No | Not provided |
| %93881 | ACETYLCHOLINE RECEPTORGANGLIONIC (ALPHA 3) AB | No | Not provided |
| %93879 | PARANEOPLASTIC AB SCREEN,IFA | No | Not provided |
| %266 | STRIATED MUSCLE AB SCREEN | No | Not provided |
| %34057 | VGCC TYPE P/Q AB | No | Not provided |
| %93882 | VOLTAGE GATED CALCIUMCHANNEL (VGCC)TYPE N AB | No | Not provided |
| %93883 | VOLTAGE GATED POTASSIUMCHANNEL (VGKC) AB | No | Not provided |
Initial panel consists of:
Paraneoplastic Antibody Screen IFA Basic
Striated Muscle Antibody with Reflex to Titer
Acetylcholine Receptor Binding Antibody
Acetylcholine Receptor Ganglionic (Alpha 3) Antibody
Voltage-Gated Calcium Channel (VGCC) Type N Antibody
Voltage-Gated Calcium Channel (VGCC) Type P/Q Antibody
Voltage-Gated Potassium Channel (VGKC) Antibody
If Paraneoplastic Antibody Screen, IFA, Basic is positive for ANNA3, then ANNA-3 Ab, IFA Titer will be performed at an additional charge (CPT code(s) 86256).
If Paraneoplastic Antibody Screen, IFA, Basic is positive for PCA-2, then PCA-2 Ab, IFA Titer will be performed at an additional charge (CPT code(s) 86256).
If Paraneoplastic Antibody Screen, IFA, Basic suggests NMO-5-IgG, then specific CBA-IFA assay will be performed at an additional charge (CPT code(s) 86255).
If Paraneoplastic Antibody Screen, IFA, Basic suggests AMPA-R, GABA-B-R, or NMDA-R, then specific CBA-IFA assay will be performed.
If Paraneoplastic Antibody Screen, IFA, Basic is positive or indeterminate, then Paraneoplastic Antibody, LB, Basic will be performed.
If Striated Muscle Antibody Screen is positive, then Striated Muscle Antibody Titer will be performed at an additional charge (CPT code(s): 86256).
If Acetylcholine Receptor Binding Antibody is positive (≥0.50) or equivocal (0.31-0.49), then Paraneoplastic Antibody, LB, Basic and Acetylcholine Receptor Modulating Antibody will both be performed at additional charges (CPT code(s) 86043).
See individual tests
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Specimen requirements | |
|---|---|
| Patient preparation | None Specified |
| Preferred specimen(s) | 6 mL frozen serum |
| Minimum volume | 3 mL |
| Transport container | Transport tube |
| Transport temperature | Refrigerated (cold packs) |
| Specimen stability | Room temperature: 48 hours Refrigerated: 14 days Frozen 21 days |
| Reject criteria | Gross hemolysis • Grossly lipemic |
Test code | Test name | Orderable separately | Reflex criteria |
|---|---|---|---|
| %93886 | NEURONAL NUCLEAR AB TYPE 3 (ANNA 3), TITER | No | If Paraneoplastic Antibody Screen, IFA, Basic is Positive for ANNA3, then ANNA-3 Ab, IFA Titer will be performed. |
| %93887 | PURKINJE CELL CYTOPLASMIC AB TYPE 2 (PCA 2),TITER | No | If Paraneoplastic Antibody Screen, IFA, Basic is Positive for PCA-2, then PCA-2 Ab, IFA Titer will be performed. |
| %93893 | AQUAPORIN 4 AB (IGG), CBA | No | If Paraneoplastic Antibody Screen, IFA, Basic suggests NMO-5-IgG, then specific CBA-IFA assay will be performed. |
| %93885 | PARANEOPLASTIC AB,CBA/IFA | No | If Paraneoplastic Antibody Screen, IFA, Basic suggests AMPA-R, GABA-B-R, or NMDA-R, then specific CBA-IFA assay will be performed. |
| %93884 | PARANEOPLASTIC ANTIBODY, LINE BLOT | No | If Paraneoplastic Antibody Screen, IFA, Basic is Positive or Indeterminate, then Paraneoplastic Antibody, LB, Basic will be performed. |
| %36210 | STRIATED MUSCLE AB TITER | No | If Striated Muscle Antibody Screen is Positive, then Striated Muscle Antibody Titer will be performed. |
| %93884 | PARANEOPLASTIC ANTIBODY, LINE BLOT | No | If Acetylcholine Receptor Binding Antibody is Positive (≥0.50) or Equivocal (0.31-0.49), then Paraneoplastic Antibody, LB, Basic will be performed. |
| %26474 | ACETYLCHOLINE RECEPTOR MODULATING ANTIBODY | No | If Acetylcholine Receptor Binding Antibody is Positive (≥0.50) or Equivocal (0.31-0.49), then Acetylcholine Receptor Modulating Antibody will be performed. |
The Result and LOINC® information listed below should not be used for electronic interface maintenance with Quest Diagnostics. Please contact the Quest Diagnostics Connectivity Help Desk for more information at 800-697-9302.
NOTE: The codes listed in the table are not orderable Test Codes
Result code | Result name | LOINC code | Component name |
|---|---|---|---|
| 45040100 | STRIATED MUSCLE AB SCREEN | 13931-1 | Striated muscle Ab |
| 85985980 | ACETYLCHOLINE RECEPTOR BINDING ANTIBODY | 11034-6 | Acetylcholine receptor binding Ab |
| 85993221 | VGCC TYPE P/Q AB | 31024-3 | Voltage-gated calcium channel Ab |
| 86015319 | TISSUE IFA OBSERVATION(S) | 57771-8 | Paraneoplastic Ab |
| 86015320 | ANNA1 (HU) AB, IFA | 33615-6 | Neuronal nuclear type 1 Ab |
| 86015321 | ANNA2 (RI) AB, IFA | 43187-4 | Neuronal nuclear type 2 Ab |
| 86015322 | ANNA3 AB, IFA | 43102-3 | Neuronal nuclear type 3 Ab |
| 86015323 | PCA1 (YO) AB, IFA | 84924-0 | Purkinje cell cytoplasmic type 1 Ab |
| 86015324 | PCA2 AB, IFA | 84925-7 | Purkinje cell cytoplasmic type 2 Ab |
| 86015325 | PCA TR (DNER) AB, IFA | 84926-5 | Purkinje cell cytoplasmic type Tr Ab |
| 86015326 | AGNA/SOX1 AB, IFA | 84927-3 | Glial nuclear type 1 Ab |
| 86015327 | AMPHIPHYSIN AB, IFA | 33422-7 | Amphiphysin Ab |
| 86015328 | CRMP5/CV2 AB, IFA | 72504-4 | CV2 Ab |
| 86015329 | ACETYLCHOLINE RECEPTOR GANGLIONIC (ALPHA 3) AB | 42233-7 | Acetylcholine receptor ganglionic neuronal Ab |
| 86015330 | VOLTAGE GATED CALCIUM CHANNEL (VGCC)TYPE N AB | 33979-6 | Voltage-gated calcium channel N type binding Ab |
| 86015331 | VOLTAGE GATED POTASSIUM CHANNEL (VGKC) AB | 41871-5 | Voltage-gated potassium channel Ab |
Result code | Result name | LOINC code | Component name |
|---|---|---|---|
| 86015343 | NEURONAL NUCLEAR AB TYPE 3 (ANNA 3), TITER | 33924-2 | Neuronal nuclear type 3 Ab |
Result code | Result name | LOINC code | Component name |
|---|---|---|---|
| 86015344 | PURKINJE CELL CYTOPLASMIC AB TYPE 2 (PCA 2),TITER | 33925-9 | Purkinje cell cytoplasmic type 2 Ab |
Result code | Result name | LOINC code | Component name |
|---|---|---|---|
| 86015342 | AQUAPORIN 4 (AQP4) AB,CBA | 43638-6 | Aquaporin 4 water channel Ab.IgG |
Result code | Result name | LOINC code | Component name |
|---|---|---|---|
| 86015332 | NMDAR1 AB, CBA | 93870-4 | N-methyl-D-aspartate receptor subunit 1 Ab |
| 86015333 | AMPAR1 AB, CBA | 93869-6 | Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab |
| 86015334 | AMPAR2 AB, CBA | 93868-8 | Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab |
| 86015335 | GABABR AB, CBA | 93867-0 | Gamma aminobutyrate B receptor Ab |
Result code | Result name | LOINC code | Component name |
|---|---|---|---|
| 86015336 | ANNA1 (HU) AB, LB | 12854-6 | Neuronal nuclear type 1 Ab |
| 86015337 | ANNA2 (RI) AB, LB | 17342-7 | Neuronal nuclear type 2 Ab |
| 86015338 | PCA1 (YO) AB, LB | 84923-2 | Purkinje cell cytoplasmic type 1 Ab |
| 86015339 | CRMP5 (CV2) AB, LB | 51797-9 | CV2 Ab |
| 86015340 | AMPHIPHYSIN AB, LB | 33423-5 | Amphiphysin Ab |
| 86015341 | GAD65 AB, LB | 13926-1 | Glutamate decarboxylase 65 Ab |
Result code | Result name | LOINC code | Component name |
|---|---|---|---|
| 85991117 | STRIATED MUSCLE AB TITER | 5372-8 | Striated muscle Ab |
Result code | Result name | LOINC code | Component name |
|---|---|---|---|
| 85987490 | ACETYLCHOLINE RECEPTOR MODULATING ANTIBODY | 11562-6 | Acetylcholine receptor modulation Ab |
| Quest Diagnostics Nichols Institute-San Juan Capistrano, CA |
| 33608 Ortega Highway |
| San Juan Capistrano, CA 92675-2042 |
Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.
*The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.
The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.